BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
See today's BioWorld
Home
» Financings Roundup
To read the full story,
subscribe
or
sign in
.
Financings Roundup
March 14, 2013
• Inovio Pharmaceuticals Inc., of Blue Bell, Pa., closed its underwritten offering of about 27.4 million shares of common stock and warrants for up to 13.7 million additional shares at 55 cents apiece. Gross proceeds were $15.1 million.
BioWorld